The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development

  1. John D. Alvarez1,3,4,
  2. Dag H. Yasui2,3,
  3. Hiroyuki Niida2,
  4. Tadashi Joh2,5,
  5. Dennis Y. Loh1, and
  6. Terumi Kohwi-Shigematsu2,6
  1. 1Nippon Roche Research Center, Kamakura 247, Japan; 2Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley, California 94720 USA

Abstract

SATB1 is expressed primarily in thymocytes and can act as a transcriptional repressor. SATB1 binds in vivo to the matrix attachment regions (MARs) of DNA, which are implicated in the loop domain organization of chromatin. The role of MAR-binding proteins in specific cell lineages is unknown. We generated SATB1-null mice to determine how SATB1 functions in the T-cell lineage. SATB1-null mice are small in size, have disproportionately small thymi and spleens, and die at 3 weeks of age. At the cellular level, multiple defects in T-cell development were observed. Immature CD3CD4CD8 triple negative (TN) thymocytes were greatly reduced in number, and thymocyte development was blocked mainly at the DP stage. The few peripheral CD4+ single positive (SP) cells underwent apoptosis and failed to proliferate in response to activating stimuli. At the molecular level, among 589 genes examined, at least 2% of genes including a proto-oncogene, cytokine receptor genes, and apoptosis-related genes were derepressed at inappropriate stages of T-cell development in SATB1-null mice. For example, IL-2Rα andIL-7Rα genes were ectopically transcribed in CD4+CD8+ double positive (DP) thymocytes. SATB1 appears to orchestrate the temporal and spatial expression of genes during T-cell development, thereby ensuring the proper development of this lineage. Our data provide the first evidence that MAR-binding proteins can act as global regulators of cell function in specific cell lineages.

Keywords

Footnotes

  • 3 These authors contributed equally to this work.

  • Present addresses: 4Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104 USA; 5Department of Medical Genetics, Osaka University, Osaka, Japan.

  • 6 Corresponding author.

  • E-MAIL terumiks{at}lbl.gov; FAX (510) 486-4545.

    • Received October 8, 1999.
    • Accepted January 26, 2000.
« Previous | Next Article »Table of Contents